Skip to content

Life Sciences

Five things a quality agreement has to settle

  • Life Sciences
  • 1 min read

A failed batch at the contract site needs an investigator, and the supply contract rarely names one.

That is the job of the quality agreement, which is usually the thinner of the two documents.

EU GMP Chapter 7, on outsourced activities, says there must be a written contract that clearly establishes the duties of each party. The contract should specify the communication processes and describe clearly who undertakes each step. The FDA's 2016 guidance on contract manufacturing uses the name most of us use: quality agreement.

Read yours against this list.

  1. Responsibilities for each GMP activity, as a table: purchasing of materials, testing, batch record review, release. One owner per row.
  2. Changes: which ones the contract site must notify, and which need approval before they are made. Chapter 7 says the acceptor should not make unauthorised changes outside the terms of the contract.
  3. Deviations and out-of-specification results: what is reported, to whom and how fast, as a number of working days.
  4. Audit rights and subcontracting. Chapter 7 says the contract should permit the contract giver to audit, and the acceptor should not subcontract without the giver's prior evaluation and approval.
  5. Records and release: who keeps which records, for how long, and who certifies the batch.

The reporting time is the usual weak spot. "Promptly" is in many agreements, and each side has its own idea of prompt.

Industries

Related

More on this subject

Batch records and the room data behind them

Under EU GMP Chapter 4, paragraph 4.11, a product with a 5-year shelf life keeps its batch documentation for at least 6 years. Environmental and BMS data that supported release is safest kept for the same period, so historian retention and storage belong in the URS for the BMS and EMS.

InsightRead

Closing supplier audit observations

A supplier audit that ends when the report is filed tends to find the same observations next time. For audits of active substance suppliers, EU GMP Chapter 5 says required corrective and preventive actions should be implemented. Classify each observation, agree an action and date with the supplier, verify the evidence, and show open actions on the approved supplier list.

InsightRead

Cpk 1.33: a convention, and what the GMP texts say instead

A Cpk of 1.33 puts the nearer specification limit 4 standard deviations from the process mean. It is a statistical convention: EU GMP Annex 15 (2015 text) and the FDA guidance of 2011 recommend statistical tools and name no index. With 10 batches the confidence interval is wide, so report the batch count and the interval.

InsightRead